Belgium · Delayed Price · Currency is EUR BioSenic Statistics
Total Valuation
BioSenic has a market cap or net worth of EUR 1.31 million. The enterprise value is 3.75 million.
| Market Cap | 1.31M |
| Enterprise Value | 3.75M |
Important Dates
The next estimated earnings date is Thursday, December 24, 2026.
| Earnings Date | Dec 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioSenic has 652.86 million shares outstanding.
| Current Share Class | 652.86M |
| Shares Outstanding | 652.86M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 603.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.53
| Current Ratio | 0.53 |
| Quick Ratio | 0.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -49.00% |
| Return on Invested Capital (ROIC) | -107.78% |
| Return on Capital Employed (ROCE) | 192.81% |
| Weighted Average Cost of Capital (WACC) | 2.61% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.67% in the last 52 weeks. The beta is -1.58, so BioSenic's price volatility has been lower than the market average.
| Beta (5Y) | -1.58 |
| 52-Week Price Change | -16.67% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 39.35 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioSenic had revenue of EUR -2.59 million and -5.98 million in losses. Loss per share was -0.01.
| Revenue | -2.59M |
| Gross Profit | -3.10M |
| Operating Income | -5.45M |
| Pretax Income | -7.77M |
| Net Income | -5.98M |
| EBITDA | -5.12M |
| EBIT | -5.45M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 501,000 in cash and 23.53 million in debt, with a net cash position of -23.03 million or -0.04 per share.
| Cash & Cash Equivalents | 501,000 |
| Total Debt | 23.53M |
| Net Cash | -23.03M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -23.60M |
| Book Value Per Share | -0.04 |
| Working Capital | -3.46M |
Cash Flow
| Operating Cash Flow | -1.25M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 330,500 |
| Net Borrowing | 950,000 |
| Free Cash Flow | -1.25M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | 210.15% |
| Pretax Margin | 299.81% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BioSenic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -166.54% |
| Shareholder Yield | -166.54% |
| Earnings Yield | -649.55% |
| FCF Yield | -96.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioSenic has an Altman Z-Score of -29.66 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -29.66 |
| Piotroski F-Score | 4 |